Genome-wide association study identifies two susceptibility loci for osteosarcoma

Nature Genetics

Volumn 45, Issue 7, 2013, Pages 799-803

  Savage, Sharon A ^a   Mirabello, Lisa ^a   Wang, Zhaoming ^b   Gastier Foster, Julie M ^c,d   Gorlick, Richard ^e   Khanna, Chand ^a   Flanagan, Adrienne M ^f,g   Tirabosco, Roberto ^g   Andrulis, Irene L ^h   Wunder, Jay S ^h   Gokgoz, Nalan ^h   Patiño Garcia, Ana ⁱ   Sierrasesúmaga, Luis ⁱ   Lecanda, Fernando ⁱ   Kurucu, Nilgün ^j   Ilhan, Inci Ergurhan ^j   Sari, Neriman ^j   Serra, Massimo ^k   Hattinger, Claudia ^k   Picci, Piero ^k   Spector, Logan G ^l   Barkauskas, Donald A ^m   Marina, Neyssa ^n,o   De Toledo, Silvia Regina Caminada ^p   Petrilli, Antonio S ^p   Amary, Maria Fernanda ^g   Halai, Dina ^g   Thomas, David M ^q   Douglass, Chester ^r   Meltzer, Paul S ^a   Jacobs, Kevin ^b   Chung, Charles C ^b   Berndt, Sonja I ^a   Purdue, Mark P ^a   Caporaso, Neil E ^a   Tucker, Margaret ^a   Rothman, Nathaniel ^a   Landi, Maria Teresa ^a   Silverman, Debra T ^a   Kraft, Peter ^r   Hunter, David J ^r   Malats, Nuria ^s   Kogevinas, Manolis ^t,u,v,w   Wacholder, Sholom ^a   Troisi, Rebecca ^a   Helman, Lee ^a   Fraumeni, Joseph F ^a   Yeager, Meredith ^b   Hoover, Robert N ^a   Chanock, Stephen J ^a   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

^d OHIO STATE UNIVERSITY   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g ROYAL NATIONAL ORTHOPAEDIC HOSPITAL   (United Kingdom)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ UNIVERSITY CLINIC OF NAVARRA   (Spain)

^j ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^k RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^l UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^m UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

ⁿ STANFORD UNIVERSITY   (United States)

^o LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

^p FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^q UNIVERSITY OF MELBOURNE   (Australia)

^r HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^s Centro Nacional de Investigations Oncológicas   (Spain)

^t CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^u HOSPITAL DEL MAR   (Spain)

^v CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^w NATIONAL SCHOOL OF PUBLIC HEALTH   (Greece)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECANASE 1; CYCLIC AMP; METABOTROPIC RECEPTOR 4;

ARTICLE; CANCER STAGING; CHROMOSOME 2P; CHROMOSOME 6P; CONTROLLED STUDY; GENE FREQUENCY; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; OSTEOSARCOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84879686634     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2645     Document Type: Article

References (45)

1. Mirabello, L., Troisi, R. & Savage, S. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the Surveillance, Epidemiology, and End Results Program. Cancer 115, 1531-1543 (2009).
2. Mirabello, L. et al. Height at diagnosis and birth-weight as risk factors for osteosarcoma. Cancer Causes Control 22, 899-908 (2011).
3. Patio-Garcia, A., Sotillo-Pieiro, E., Modesto, C. & Sierrases-Maga, L. Analysis of the human tumour necrosis factor-α (TNFα) gene promoter polymorphisms in children with bone cancer. J. Med. Genet. 37, 789-792 (2000).
4. Ruza, E., Sotillo, E., Sierrasesúmaga, L., Azcona, C. & Patiño-Garcia, A. Analysis of polymorphisms of the vitamin D receptor, estrogen receptor, and collagen Iα1 genes and their relationship with height in children with bone cancer. J. Pediatr. Hematol. Oncol. 25, 780-786 (2003).
5. Savage, S.A. et al. Germ-line genetic variation of TP53 in osteosarcoma. Pediatr. Blood Cancer 49, 28-33 (2007).
6. Savage, S.A. et al. Analysis of genes critical for growth regulation identifies Insulin-like Growth Factor 2 Receptor variations with possible functional significance as risk factors for osteosarcoma. Cancer Epidemiol. Biomarkers Prev. 16, 1667-1674 (2007).
7. Koshkina, N.V. et al. Exploratory analysis of Fas gene polymorphisms in pediatric osteosarcoma patients. J. Pediatr. Hematol. Oncol. 29, 815-821 (2007).
8. Toffoli, G. et al. Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival. Clin. Cancer Res. 15, 3550-3556 (2009).
9. Hu, Y.S. et al. Association between TGFBR1*6A and osteosarcoma: a Chinese case-control study. BMC Cancer 10, 169 (2010).
10. Mirabello, L. et al. Genetic variation at chromosome 8q24 in osteosarcoma cases and controls. Carcinogenesis 31, 1400-1404 (2010).
11. Mirabello, L. et al. A comprehensive candidate gene approach identifies genetic variation associated with osteosarcoma. BMC Cancer 11, 209 (2011).
12. Savage, S.A. & Mirabello, L. Using epidemiology and genomics to understand osteosarcoma etiology. Sarcoma 2011, 548151 (2011).
13. Postel-Vinay, S. et al. Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma. Nat. Genet. 44, 323-327 (2012).
14. Papaemmanuil, E. et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat. Genet. 41, 1006-1010 (2009).
15. Thomas, G. et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat. Genet. 40, 310-315 (2008).
16. Amundadottir, L. et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat. Genet. 41, 986-990 (2009).
17. Rothman, N. et al. A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat. Genet. 42, 978-984 (2010).
18. Landi, M.T. et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am. J. Hum. Genet. 85, 679-691 (2009).
19. Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447, 661-678 (2007).
20. Li, J. et al. GWAS of blood cell traits identifies novel associated loci and epistatic interactions in Caucasian and African-American children. Hum. Mol. Genet. 22, 1457-1464 (2013).
21. Gieger, C. et al. New gene functions in megakaryopoiesis and platelet formation. Nature 480, 201-208 (2011).
22. Qayyum, R. et al. A meta-analysis and genome-wide association study of platelet count and mean platelet volume in African Americans. PLoS Genet. 8, e1002491 (2012).
23. Slager, S.L. et al. Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood 120, 843-846 (2012).
24. Rapley, E.A. et al. A genome-wide association study of testicular germ cell tumor. Nat. Genet. 41, 807-810 (2009).
25. 1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073 (2010).
26. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
27. Molyneux, S.D. et al. Prkar1a is an osteosarcoma tumor suppressor that defines a molecular subclass in mice. J. Clin. Invest. 120, 3310-3325 (2010).
28. Griffin, K.J. et al. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions. J. Med. Genet. 41, 923-931 (2004).
29. Cowan, R.W., Seidlitz, E.P. & Singh, G. Glutamate signaling in healthy and diseased bone. Front. Endocrinol. (Lausanne) 3, 89 (2012).
30. Skerry, T.M. The role of glutamate in the regulation of bone mass and architecture. J. Musculoskelet. Neuronal Interact. 8, 166-173 (2008).
31. Kalariti, N., Lembessis, P. & Koutsilieris, M. Characterization of the glutametergic system in MG-63 osteoblast-like osteosarcoma cells. Anticancer Res. 24, 3923-3929 (2004).
32. Chang, H.J. et al. Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin. Cancer Res. 11, 3288-3295 (2005).
33. Brocke, K.S. et al. Glutamate receptors in pediatric tumors of the central nervous system. Cancer Biol. Ther. 9, 455-468 (2010).
34. Stepulak, A. et al. Expression of glutamate receptor subunits in human cancers. Histochem. Cell Biol. 132, 435-445 (2009).
35. Luksch, H. et al. Silencing of selected glutamate receptor subunits modulates cancer growth. Anticancer Res. 31, 3181-3192 (2011).
36. Hirschhorn, J.N. & Lettre, G. Progress in genome-wide association studies of human height. Horm. Res. 71 (suppl. 2), 5-13 (2009).
37. Wang, Z. et al. Improved imputation of common and uncommon SNPs with a new reference set. Nat. Genet. 44, 6-7 (2012).
38. Howie, B.N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
39. Purdue, M.P. et al. Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3. Nat. Genet. 43, 60-65 (2011).
40. Fearnhead, P. SequenceLDhot: detecting recombination hotspots. Bioinformatics 22, 3061-3066 (2006).
41. Fearnhead, P. & Donnelly, P. Approximate likelihood methods for estimating local recombination rates. J. R. Stat. Soc. Series B Stat. Methodol. 64, 657-680 (2002).
42. Crawford, D.C. et al. Evidence for substantial fine-scale variation in recombination rates across the human genome. Nat. Genet. 36, 700-706 (2004).
43. Li, N. & Stephens, M. Modeling linkage disequilibrium and identifying recombination hotspots using single-nucleotide polymorphism data. Genetics 165, 2213-2233 (2003).
44. Luna, A. & Nicodemus, K.K. snp.plotter: an R-based SNP/haplotype association and linkage disequilibrium plotting package. Bioinformatics 23, 774-776 (2007).
45. Marchini, J., Howie, B., Myers, S., McVean, G. & Donnelly, P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 39, 906-913 (2007).